Merck KGaA Investment in Portugal at Risk as Bills Are Unpaid

Merck KGaA’s future research and development investments in Portugal are at risk because of unpaid hospital bills, Gangolf Schrimpf, a spokesman for the Darmstadt, Germany-based chemicals and drugmaker, said today, confirming a report in Financial Times Deutschland.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.